|
|
Volumn 29, Issue 3, 2008, Pages 296-304
|
|
Arsenic trioxide: Safety issues and their management
a
a
|
|
Author keywords
Antitumor pharmacology; Arsenicals; Drug design; Prodrugs
|
|
Indexed keywords
ARSENIC TRIOXIDE;
CORTICOSTEROID DERIVATIVE;
DEXAMETHASONE;
POTASSIUM CHANNEL;
RETINOIC ACID;
BLOOD BRAIN BARRIER;
BLOOD TOXICITY;
CARDIOTOXICITY;
DRUG ABSORPTION;
DRUG BLOOD LEVEL;
DRUG EXCRETION;
DRUG SAFETY;
DRUG TRANSPORT;
DRUG WITHDRAWAL;
DYSPEPSIA;
EDEMA;
FLUID RETENTION;
GASTROINTESTINAL SYMPTOM;
HEADACHE;
HEART ARRHYTHMIA;
HEART REPOLARIZATION;
HEPATITIS;
HERPES VIRUS INFECTION;
HUMAN;
INTESTINE ABSORPTION;
LEUKOCYTOSIS;
LUNG INFILTRATE;
NAUSEA;
NEUROTOXICITY;
NEUTROPENIA;
NONHUMAN;
PROMYELOCYTIC LEUKEMIA;
QT PROLONGATION;
RASH;
REVIEW;
SIDE EFFECT;
SKIN MANIFESTATION;
SKIN PIGMENTATION;
THROMBOCYTOPENIA;
TORSADE DES POINTES;
TREATMENT RESPONSE;
ADMINISTRATION, ORAL;
ANTINEOPLASTIC AGENTS;
ARSENICALS;
CLINICAL TRIALS AS TOPIC;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG TOXICITY;
HUMANS;
LETHAL DOSE 50;
OXIDES;
PRODRUGS;
|
|
EID: 39849088561
PISSN: 16714083
EISSN: 17457254
Source Type: Journal
DOI: 10.1111/j.1745-7254.2008.00771.x Document Type: Review |
|
Times cited : (55)
|
|
References (68)
|
